clined to /H1101113% by the end of the 28-day treatment period. Four (3.7%) of the 109patients withdrew due to nausea, allwithin the ﬁrst 12 days of the study. There was no evidence of adverse events that could be associated with anallergic reaction to study medication forpatients with anti-AC2993 antibodies. CONCLUSIONS — Exendin-4 was originally isolated from the salivary se-cretions of the lizard Heloderma suspec- tum (Gila monster), in which it